loader2
Login Open ICICI 3-in-1 Account
  • Text Size
  • Text to Speech
  • Color Contrast
  • Pause Animations

Jeena Sikho Lifecare Results: Latest Quarterly Results & Analysis

Open Free Trading Account Online with ICICIDIRECT
+91
Jeena Sikho Lifecare Ltd. 09 Feb 2026 15:46 PM

Q3FY26 Quarterly Result Announced for Jeena Sikho Lifecare Ltd.

Pharmaceuticals company Jeena Sikho Lifecare announced Q3FY26 results

  • Revenue: Rs 22,166 crore against Rs 11,569 crore during Q3FY25, change 92%.
  • EBITDA: Rs 10,080 crore against Rs 2,961 crore during Q3FY25, change 240%.
  • EBITDA Margin: 45% for Q3FY26.
  • PBT: Rs 8,906 crore against Rs 1,774 crore during Q3FY25, change 402%.
  • PAT: Rs 6,673 crore against Rs 1,321 crore during Q3FY25, change 405%.
  • EPS: Rs 5.37 for Q3FY26.

Acharya Manish Ji, Managing director, said: Jeena Sikho has delivered yet another robust quarter, continuing its strong momentum from the first half of FY26. The Company’s performance in Q3 further strengthens its track record of consistent growth and operational excellence, with solid contributions from both business verticals, Ayurveda Healthcare Services and Ayurveda Healthcare Products.

Revenue from Operations grew by an impressive 92% YOY in Q3 and 78% YOY for 9MFY26. This growth was primarily driven by sustained volume expansion across business segments and the continued strengthening of our pan-India presence.

Profitability remained on a strong footing, with EBITDA margins steady at 45% in Q3, reflecting operational efficiency despite ongoing investments in business expansion. On a year-to-date basis, 9MFY26 EBITDA margins improved significantly to 46%, compared to 29% in FY25, underscoring the growing scalability and efficiency of our business model.

In our services segment, patient volumes remained robust across both IPD and OPD formats, resulting in higher throughput and overall service revenue. Our Day Care centres and Video-Call consultations have shown tremendous traction, further augmenting our reach and accessibility. The Company continues to benefit from increasing nationwide awareness and acceptance of Ayurvedic healthcare solutions.

Looking ahead, the services business is well-positioned to deliver sustained growth, supported by a strong bed pipeline. We currently have 475 beds under development, providing good visibility for capacity additions across existing and new facilities, which will drive further volume-led growth in the coming quarters.

On the innovation front, we are gearing up to launch the Jeena Sikho Health Card, an initiative designed to offer enhanced value and convenience to our customers. More details on this will be shared in the upcoming quarters.

Our Ayurveda healthcare products segment also continues to gain momentum, supported by successful recent product launches and growing demand for our legacy portfolio. The category’s strong performance validates our strategy of product diversification and consistent focus on quality and innovation.

In conclusion, Jeena Sikho remains firmly positioned to sustain its strong growth trajectory. With strategic initiatives in capacity expansion, market diversification (including international expansion), operational excellence, and a differentiated product portfolio, the Company is well-prepared to deliver consistent growth and long-term value for all stakeholders.

Result PDF

Disclaimer – I ICICI Securities Ltd. ( I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is acting as a distributor to solicit bond related products. All disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. Investments in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein mentioned are solely for informational and educational purpose.
Download App

Download Our App

Get it on google Play Store Download on the App Store
market app